5 reasons
pet owners love bravecto®

Dog and Cat

1

Long-lasting protection

12 Weeks

BRAVECTO lasts nearly
3X longer than monthly treatments*

2

Extra Outdoor Protection6

Pet owners whose dogs spend over 12 hours a day outdoors know the importance of extra protection and 93% of them prefer Bravecto.

Swim

1 in 4 swim

Visit the Dog Park

1 in 3 visit the dog park

Access to the Woods

1 in 2.5 have access to the woods

Leash in High Grass

1 in 2 walk off leash in high grass

3

Convenient

BRAVECTO provides the convenience of 12 weeks of protection against fleas and ticks for dogs and cats, and fewer chances to forget protection than monthly products.

BRAVECTO Chew for Dogs is flavored to appeal to dogs for easy acceptance.

BRAVECTO Topical Solution is available for both cats and dogs. The easy application is especially convenient and less hassle for cats because you apply it less often.

4

SATISFACTION WITH HOW IT WORKS6

In a survey of dog owners, 96% were either satisfied or very satisfied with the single-dose, longer duration of BRAVECTO.

96 Percent Satisfied

They identified the most important benefits as convenience, the 12-week dosing interval, and less-frequent dosing than monthly flea and tick medications.

5

Vets Recommend Bravecto

"We don't intend to forget our pet's medication, but it happens. We are happy that Bravecto is going to provide that 12-week* protection."

Dr. Elizabeth Clyde
Clyde's Animal Clinic, Illinios

SEE IF YOUR VET CARRIES BRAVECTO®

By prescription only. Enter your ZIP code to see which veterinarians carry BRAVECTO. Start protecting your pet today.

Start today and your pet's next BRAVECTO treatment would be:
January 12, 2020

SAVE MORE WITH BRAVECTO

As a single 12-week* treatment, BRAVECTO can be more cost-effective than monthly treatments. See how you can save even more with a special offer.

Save more image

Dogs over 123.0 lb should be administered the appropriate combination of chew or topical treatments.

Save more image

Cats over 27.5 lb. should be administered the appropriate combination of tubes.

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

BRAVECTO kills fleas and prevents flea infestations for 12 weeks. BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills black-legged ticks for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION
BRAVECTO has not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. BRAVECTO Chew: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

References:
1. BRAVECTO Chew [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2. BRAVECTO Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3. BRAVECTO Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 4. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 5. Freedom of Information Summary, NADA 141-459. Approved July 20, 2016. 6. Lavan et al. J Vet Sci Technol. 2017;8:439. 7. Dryden et al. Parasites & Vectors. 2015;8:364. 8. Dryden et al. Parasites & Vectors. 2018;11:422. 9. Burgio et al. Parasites & Vectors. 2016;9:626. 10. CAPC website, Guidelines–Ticks. Available at www.capcvet.org/guidelines/ticks/. Updated April 2017. Accessed December 20, 2018. 11. Walther et al. Parasites & Vectors. 2014;7:86. 12. Walther et al. Parasites & Vectors. 2014;7:481.

SEE HOW BRAVECTO®
IS MAKING A DIFFERENCE

Across the US and around the world, veterinarians are recommending the 12-week* protection of BRAVECTO for dogs and cats at their clinics. See why vets and pet owners alike love the difference BRAVECTO makes.

HEAR WHY PET OWNERS LOVE USING BRAVECTO

Christina McKee

"It's a very easy product to use... It's easy for [my dogs] to take in and they love taking it."

John O'Neal

"At this point, I would never consider using anything else."

Lauren and Brian Herron

"We were using a topical once a month treatment and we were still having a lot of issues…so [our veterinarian] recommended Bravecto."

9 OUT OF 10
pet owners said they preferred Bravecto.6

Get more facts

Dog icon
HEAR WHY VETERINARIANS ACROSS THE COUNTRY RECOMMEND BRAVECTO TO DOG OWNERS

Dr. Randal Bennett
Texas

"There's no better joy than to see someone who doesn’t have fleas in their household."

Dr. Sandy Merchant
Louisiana

"Currently, I have one dog... he is my son's guide dog, and we have him on Bravecto. I find that using a chew every 12-weeks* is very easy to remember and administer."

Dr. Kira Ernst
New Jersey

"It's so convenient because it lasts for the 12 weeks.* You can give it and not have to worry about giving it every month."

Cat icon
HEAR WHY VETERINARIANS ACROSS THE COUNTRY RECOMMEND BRAVECTO TO CAT OWNERS

Dr. Jeff Werber
California

"I love the fact that it's 12-week* protection. Cats are not always easy to deal with."

Dr. Romanie Walter
Illinois

"We see a lot of indoor cats that do acquire fleas. This is a way for you to protect your home, protect your cat with a very safe product."

Dr. Cathy Lund
Rhode Island

"It was truly amazing. It was easy to use. It was for cats, odorless which is very, very important… I love it."

Share how BRAVECTO has made a difference in the life of you and your pet!

TELL US YOUR BRAVECTO STORY
 
 
 
   
   

I irrevocably grant to Intervet Inc., a subsidiary of Merck & Co., Inc. and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns (collectively, "MERCK ANIMAL HEALTH"), the right to take, record, publish or obtain testimonials or other statements from me (collectively, the "Statements") and use, copy, modify, adapt, distribute, publish, display, exhibit and otherwise publish or display in any media, by any means, methods and technologies now known or hereafter to become known, either in whole or in part, the Statements for commercial and business purposes, including, but not limited to, educational, advertising, marketing and promotional materials.

I agree that no advertisement or other material need be submitted to me for any approval. I further waive any and all rights that I may have over the use, distribution, transfer, display, exhibition or other publication of any Statements, including, without limitation, any right to inspect and/or approve such use, publication, distribution, transfer, display, exhibition or other exploitation so long as such Statements are not substantively altered.

I hereby release and discharge, and agree to release and discharge, MERCK ANIMAL HEALTH and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns from, and shall neither sue nor bring any proceeding against any such parties for, any claim or cause of action, whether now known or unknown, for defamation, violation of any moral rights, invasion of right of privacy, publicity or personality or any similar matter, or based upon or relating to any use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements.

I further agree that MERCK ANIMAL HEALTH has the right to attribute the Statements (or statements in different words which have substantially the same meaning) to me, which is an expression of my personal experience and belief, including, without limitation, the use of my name and image in connection therewith. I further acknowledge that I am to receive no compensation from MERCK ANIMAL HEALTH relating to the use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements as set forth in this Release or the use of my name and/or image in connection therewith.

Nothing herein will constitute any obligation on MERCK ANIMAL HEALTH to make any use of the Statements or use of any of the rights set forth herein.

I represent and warrant that I am over the age of eighteen (18) years and have read and understand the contents of this Release.

 

SEE IF YOUR VET CARRIES BRAVECTO®

By prescription only. Enter your ZIP code to see which veterinarians carry BRAVECTO. Start protecting your pet today.

Start today and your pet’s next BRAVECTO treatment would be:
January 12, 2020

SAVE MORE WITH BRAVECTO

As a single 12-week* treatment, BRAVECTO can be more cost-effective than monthly treatments. See how you can save even more with a special offer.

Save more image

Dogs over 123.0 lb should be administered the appropriate combination of chew or topical treatments.

Save more image

Cats over 27.5 lb. should be administered the appropriate combination of tubes.

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

BRAVECTO kills fleas and prevents flea infestations for 12 weeks. BRAVECTO Chew and BRAVECTO Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. BRAVECTO Topical Solution for Cats kills black-legged ticks for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION
BRAVECTO has not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. BRAVECTO Chew: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO is not effective against lone star ticks beyond 8 weeks of dosing. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Seizures have been reported in dogs receiving isoxoline class drugs, even in dogs without a history of seizures. Use caution in dogs with a history of seizures or neurologic disorders. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

References:
1. BRAVECTO Chew [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2. BRAVECTO Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3. BRAVECTO Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 4. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 5. Freedom of Information Summary, NADA 141-459. Approved July 20, 2016. 6. Lavan et al. J Vet Sci Technol. 2017;8:439. 7. Dryden et al. Parasites & Vectors. 2015;8:364. 8. Dryden et al. Parasites & Vectors. 2018;11:422. 9. Burgio et al. Parasites & Vectors. 2016;9:626. 10. CAPC website, Guidelines–Ticks. Available at www.capcvet.org/guidelines/ticks/. Updated April 2017. Accessed December 20, 2018. 11. Walther et al. Parasites & Vectors. 2014;7:86. 12. Walther et al. Parasites & Vectors. 2014;7:481.

Buy Bravecto